Designed hybrid TPR peptide targeting Hsp90 as a novel anticancer agent

Horibe, Tomohisa; Kohno, Masayuki; Haramoto, Mari; Ohara, Koji; Kawakami, Koji
January 2011
Journal of Translational Medicine;2011, Vol. 9 Issue 1, p1
Academic Journal
Background: Despite an ever-improving understanding of the molecular biology of cancer, the treatment of most cancers has not changed dramatically in the past three decades and drugs that do not discriminate between tumor cells and normal tissues remain the mainstays of anticancer therapy. Since Hsp90 is typically involved in cell proliferation and survival, this is thought to play a key role in cancer, and Hsp90 has attracted considerable interest in recent years as a potential therapeutic target. Methods: We focused on the interaction of Hsp90 with its cofactor protein p60/Hop, and engineered a cellpermeable peptidomimetic, termed "hybrid Antp-TPR peptide", modeled on the binding interface between the molecular chaperone Hsp90 and the TPR2A domain of Hop. Results: It was demonstrated that this designed hybrid Antp-TPR peptide inhibited the interaction of Hsp90 with the TPR2A domain, inducing cell death of breast, pancreatic, renal, lung, prostate, and gastric cancer cell lines in vitro. In contrast, Antp-TPR peptide did not affect the viability of normal cells. Moreover, analysis in vivo revealed that Antp- TPR peptide displayed a significant antitumor activity in a xenograft model of human pancreatic cancer in mice. Conclusion: These results indicate that Antp-TPR peptide would provide a potent and selective anticancer therapy to cancer patients.


Related Articles

  • The critical roles of endoplasmic reticulum chaperones and unfolded protein response in tumorigenesis and anticancer therapies. Luo, B; Lee, A S // Oncogene;2/14/2013, Vol. 32 Issue 7, p805 

    Cancer progression is characterized by rapidly proliferating cancer cells that are in need of increased protein synthesis. Therefore, enhanced endoplasmic reticulum (ER) activity is required to facilitate the folding, assembly and transportation of membrane and secretory proteins. These...

  • Mitochondrial matrix proteases as novel therapeutic targets in malignancy. Goard, C A; Schimmer, A D // Oncogene;5/22/2014, Vol. 33 Issue 21, p2690 

    Although mitochondrial function is often altered in cancer, it remains essential for tumor viability. Tight control of protein homeostasis is required for the maintenance of mitochondrial function, and the mitochondrial matrix houses several coordinated protein quality control systems. These...

  • Silibinin Causes Apoptosis and Cell Cycle Arrest in Some Human Pancreatic Cancer Cells. Yakun Ge; Yuanxin Zhang; Yunpeng Chen; Quanshun Li; Jun Chen; Ying Dong; Wei Shi // International Journal of Molecular Sciences;Aug2011, Vol. 12 Issue 8, p4861 

    Silibinin, an effective anti-cancer and chemopreventive agent in various epithelial cancer models, has been reported to inhibit cancer cell growth through mitogenic signaling pathways. However, whether it can inhibit human pancreatic carcinoma growth and what are the underlying mechanisms is...

  • Enhanced antitumor effects of DC-activated CIKs to chemotherapy treatment in a single cohort of advanced non-small-cell lung cancer patients. Yang, Lili; Ren, Baozhu; Li, Hui; Yu, Jinpu; Cao, Shui; Hao, Xishan; Ren, Xiubao // Cancer Immunology, Immunotherapy;Jan2013, Vol. 62 Issue 1, p65 

    Cytokine-induced killer (CIK) cells show cytolytic activity against tumor. The purpose of this study was to evaluate the antitumor effect of dendritic cell (DC)-activated CIK cells in vitro and their clinical efficacy of DC-activated CIK cells in combination with chemotherapy (abbreviated below...

  • Inhibition on Proteasome β1 Subunit Might Contribute to the Anti-Cancer Effects of Fangchinoline in Human Prostate Cancer Cells. Li, Dong; Lu, Yu; Sun, Peng; Feng, Li-Xing; Liu, Miao; Hu, Li-Hong; Wu, Wan-Ying; Jiang, Bao-Hong; Yang, Min; Qu, Xiao-Bo; Guo, De-An; Liu, Xuan // PLoS ONE;29/10/2015, Vol. 10 Issue 10, p1 

    Fangchinoline is a bisbenzylisoquinoline alkaloid isolated from Radix Stephaniae tetrandrae S. Moore. Fangchinoline and its structure analogue, tetrandrine, exhibited direct binding affinity with recombinant human proteasome β1 subunit and also inhibited its activity in vitro. In cultured...

  • Secretion of extracellular hsp90α via exosomes increases cancer cell motility: a role for plasminogen activation. McCready, Jessica; Sims, Jessica D.; Doug Chan; Jay, Daniel G. // BMC Cancer;2010, Vol. 10, p294 

    Background: Metastasis is a multi-step process that is responsible for the majority of deaths in cancer patients. Current treatments are not effective in targeting metastasis. The molecular chaperone hsp90α is secreted from invasive cancer cells and activates MMP-2 to enhance invasiveness,...

  • Heat Shock Proteins: A Potential Anticancer Target. Sankhala, Kamalesh K.; Mita, Monica M.; Mita, Alain C.; Takimoto, Chris H. // Current Drug Targets;Dec2011, Vol. 12 Issue 14, p2001 

    Heat shock proteins (Hsp) are highly conserved proteins and their expression is dependent on the level of various cellular stresses. Hsp work as a molecular chaperon for several cellular proteins and have cytoprotective roles. Their function is essential for normal cell viability and growth....

  • Design of Disruptors of the Hsp90–Cdc37 Interface. D'Annessa, Ilda; Hurwitz, Naama; Pirota, Valentina; Beretta, Giovanni Luca; Tinelli, Stella; Woodford, Mark; Freccero, Mauro; Mollapour, Mehdi; Zaffaroni, Nadia; Wolfson, Haim; Colombo, Giorgio // Molecules;1/15/2020, Vol. 25 Issue 2, p360 

    The molecular chaperone Hsp90 is a ubiquitous ATPase-directed protein responsible for the activation and structural stabilization of a large clientele of proteins. As such, Hsp90 has emerged as a suitable candidate for the treatment of a diverse set of diseases, such as cancer and...

  • Immunology: Deregulation required? Flintoft, Louisa; McCarthy, Nicola // Nature Reviews Cancer;Oct2004, Vol. 4 Issue 10, p754 

    The article focuses on the regulatory T cells that is suspected to restrict an effective antitumor response. Recent studies have indicated that when self recognizing T cells are present in the blood of cancer patients, regulatory T cells become activated and shut down the antitumor response. In...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics